Probo Medical Announces New Leadership Roster
Probo Medical, a key player in the field of diagnostic imaging solutions, has recently made important changes in its executive leadership team. The company has appointed Michael Asmer as its new Chairman of the Board and Greg Kopulos as its Chief Executive Officer. This shift represents a significant step for Probo as it aims to improve its services and broaden its presence within the healthcare industry.
The Vision of Michael Asmer
Michael Asmer steps into the vital role of Chairman after serving as the Chief Executive Officer of Probo Medical. He brings a wealth of experience from the healthcare sector, having founded MedCorp—a company that Probo acquired in 2018. Asmer's resume includes leadership roles at reputable organizations like Physician Sales and Service and Henry Schein.
Looking back on his journey, Asmer shared, "I am tremendously proud of what our team has accomplished over the last five years at Probo and am also excited for what lies ahead. With the integration of recent acquisitions, Probo enters a new phase of growth where we can support our customers with a comprehensive offering of diagnostic imaging solutions." His dedication to innovation and customer service will be essential in guiding Probo's future strategic initiatives.
Introducing Greg Kopulos
Greg Kopulos, now at the helm as CEO, joins Probo Medical following a successful stint at Chartis, where he managed the Clinical Quality Solutions business. With 20 years of experience at GE Healthcare—including roles like Chief Operating Officer of Global Services and Senior Vice President of Strategy—Kopulos is well-prepared to guide Probo into this new chapter.
Kopulos shared his excitement for the position, stating, "Probo is well on its way to becoming a global leader in diagnostic imaging solutions. I am humbled and excited to build on the great work of Michael and the entire Probo team. With the continued investment in and integration of our prior acquisitions, Probo has never been better positioned to help our customers deliver quality care to their patients while providing needed cost savings." His vision aligns seamlessly with Probo's growth goals and commitment to excellence in healthcare.
Strengthening Market Position
Probo Medical enjoys strong backing from Avista Healthcare Partners, a leading private equity firm that specializes exclusively in healthcare investments. With over $8 billion invested in more than 45 healthcare businesses globally, Probo is set for ambitious growth.
As Probo continues to broaden its portfolio of diagnostic imaging products and services—including equipment sales, service, rental, repair, and installation—it maintains a sharp focus on innovative solutions that meet the changing needs of its customers. Their expertise plays a key role in shaping the future of diagnostic imaging.
About Probo Medical
Probo Medical is recognized as a versatile solutions provider in the realm of diagnostic imaging, known for its extensive service offerings. The company is committed to delivering high-quality equipment solutions and exceptional support to healthcare professionals.
Frequently Asked Questions
What is the significance of the leadership changes at Probo Medical?
The leadership changes represent a strategic approach aimed at fostering growth and innovation, with experienced leaders in key positions focused on improving service offerings.
Who are the new leaders at Probo Medical?
Michael Asmer has taken on the role of Chairman, while Greg Kopulos serves as CEO, both bringing significant experience in the industry to their roles.
How will these appointments affect Probo Medical's growth?
This new leadership is poised to propel Probo's growth strategy forward, utilizing their expertise to innovate and expand service capabilities.
What type of services does Probo Medical offer?
Probo Medical offers a wide array of diagnostic imaging services, which include equipment sales, rental, repair, installation, and service support.
Who backs Probo Medical financially?
Probo Medical is financially supported by Avista Healthcare Partners, a distinguished private equity firm that invests heavily in the healthcare sector.
